By Alex Philippidis

NEW YORK (GenomeWeb News) — The European Molecular Biology Laboratory is "well prepared" to tackle challenges posed by the growth of 'big' science as it begins planning its research and operations strategy for the five years starting in 2012, Director General Iain Mattaj said in the institution's annual report for the fiscal year ended March 31.

The report showed a decline in grant funding, especially by the European Community, that pushed EMBL into the red.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.